Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Title||A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting|
|Recruitment||Active, not recruiting|
|Abramson Cancer Center of the University of Pennsylvania||Philadelphia||Pennsylvania||19104||United States||Details|